1789 related articles for article (PubMed ID: 10426993)
1. Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA.
Bauer S; Groh V; Wu J; Steinle A; Phillips JH; Lanier LL; Spies T
Science; 1999 Jul; 285(5428):727-9. PubMed ID: 10426993
[TBL] [Abstract][Full Text] [Related]
2. Activation of V gamma 9V delta 2 T cells by NKG2D.
Rincon-Orozco B; Kunzmann V; Wrobel P; Kabelitz D; Steinle A; Herrmann T
J Immunol; 2005 Aug; 175(4):2144-51. PubMed ID: 16081780
[TBL] [Abstract][Full Text] [Related]
3. An activating immunoreceptor complex formed by NKG2D and DAP10.
Wu J; Song Y; Bakker AB; Bauer S; Spies T; Lanier LL; Phillips JH
Science; 1999 Jul; 285(5428):730-2. PubMed ID: 10426994
[TBL] [Abstract][Full Text] [Related]
4. Interactions of human NKG2D with its ligands MICA, MICB, and homologs of the mouse RAE-1 protein family.
Steinle A; Li P; Morris DL; Groh V; Lanier LL; Strong RK; Spies T
Immunogenetics; 2001; 53(4):279-87. PubMed ID: 11491531
[TBL] [Abstract][Full Text] [Related]
5. MICA/NKG2D-mediated immunogene therapy of experimental gliomas.
Friese MA; Platten M; Lutz SZ; Naumann U; Aulwurm S; Bischof F; Bühring HJ; Dichgans J; Rammensee HG; Steinle A; Weller M
Cancer Res; 2003 Dec; 63(24):8996-9006. PubMed ID: 14695218
[TBL] [Abstract][Full Text] [Related]
6. Systemic NKG2D down-regulation impairs NK and CD8 T cell responses in vivo.
Wiemann K; Mittrücker HW; Feger U; Welte SA; Yokoyama WM; Spies T; Rammensee HG; Steinle A
J Immunol; 2005 Jul; 175(2):720-9. PubMed ID: 16002667
[TBL] [Abstract][Full Text] [Related]
7. NKG2D recruits two distinct adapters to trigger NK cell activation and costimulation.
Gilfillan S; Ho EL; Cella M; Yokoyama WM; Colonna M
Nat Immunol; 2002 Dec; 3(12):1150-5. PubMed ID: 12426564
[TBL] [Abstract][Full Text] [Related]
8. Major histocompatibility complex class I-related chain A and UL16-binding protein expression on tumor cell lines of different histotypes: analysis of tumor susceptibility to NKG2D-dependent natural killer cell cytotoxicity.
Pende D; Rivera P; Marcenaro S; Chang CC; Biassoni R; Conte R; Kubin M; Cosman D; Ferrone S; Moretta L; Moretta A
Cancer Res; 2002 Nov; 62(21):6178-86. PubMed ID: 12414645
[TBL] [Abstract][Full Text] [Related]
9. A novel ligand for the NKG2D receptor activates NK cells and macrophages and induces tumor immunity.
Diefenbach A; Hsia JK; Hsiung MY; Raulet DH
Eur J Immunol; 2003 Feb; 33(2):381-91. PubMed ID: 12645935
[TBL] [Abstract][Full Text] [Related]
10. Regulation of cutaneous malignancy by gammadelta T cells.
Girardi M; Oppenheim DE; Steele CR; Lewis JM; Glusac E; Filler R; Hobby P; Sutton B; Tigelaar RE; Hayday AC
Science; 2001 Oct; 294(5542):605-9. PubMed ID: 11567106
[TBL] [Abstract][Full Text] [Related]
11. Receptors and lytic mediators regulating anti-tumor activity by the leukemic killer T cell line TALL-104.
Brando C; Mukhopadhyay S; Kovacs E; Medina R; Patel P; Catina TL; Campbell KS; Santoli D
J Leukoc Biol; 2005 Aug; 78(2):359-71. PubMed ID: 15937142
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathological significance of major histocompatibility complex class I-related chain a and B expression in thyroid cancer.
Xu X; Rao G; Gaffud MJ; Ding HG; Maki G; Klingemann HG; Groh V; Spies T; Caillat-Zucman S; Gattuso P; Plate J; Prinz RA
J Clin Endocrinol Metab; 2006 Jul; 91(7):2704-12. PubMed ID: 16621903
[TBL] [Abstract][Full Text] [Related]
13. CD4+NKG2D+ T cells in Crohn's disease mediate inflammatory and cytotoxic responses through MICA interactions.
Allez M; Tieng V; Nakazawa A; Treton X; Pacault V; Dulphy N; Caillat-Zucman S; Paul P; Gornet JM; Douay C; Ravet S; Tamouza R; Charron D; Lémann M; Mayer L; Toubert A
Gastroenterology; 2007 Jun; 132(7):2346-58. PubMed ID: 17570210
[TBL] [Abstract][Full Text] [Related]
14. Lymphocyte activation via NKG2D: towards a new paradigm in immune recognition?
Vivier E; Tomasello E; Paul P
Curr Opin Immunol; 2002 Jun; 14(3):306-11. PubMed ID: 11973127
[TBL] [Abstract][Full Text] [Related]
15. T cell antigen receptor engagement and specificity in the recognition of stress-inducible MHC class I-related chains by human epithelial gamma delta T cells.
Wu J; Groh V; Spies T
J Immunol; 2002 Aug; 169(3):1236-40. PubMed ID: 12133944
[TBL] [Abstract][Full Text] [Related]
16. NKG2D-mediated cytotoxicity toward oligodendrocytes suggests a mechanism for tissue injury in multiple sclerosis.
Saikali P; Antel JP; Newcombe J; Chen Z; Freedman M; Blain M; Cayrol R; Prat A; Hall JA; Arbour N
J Neurosci; 2007 Jan; 27(5):1220-8. PubMed ID: 17267578
[TBL] [Abstract][Full Text] [Related]
17. Natural killer cells: stress out, turn on, tune in.
Diefenbach A; Raulet DH
Curr Biol; 1999 Nov; 9(22):R851-3. PubMed ID: 10574749
[TBL] [Abstract][Full Text] [Related]
18. HLA class I, NKG2D, and natural cytotoxicity receptors regulate multiple myeloma cell recognition by natural killer cells.
Carbone E; Neri P; Mesuraca M; Fulciniti MT; Otsuki T; Pende D; Groh V; Spies T; Pollio G; Cosman D; Catalano L; Tassone P; Rotoli B; Venuta S
Blood; 2005 Jan; 105(1):251-8. PubMed ID: 15328155
[TBL] [Abstract][Full Text] [Related]
19. Engagement of TLR3, TLR7, and NKG2D regulate IFN-gamma secretion but not NKG2D-mediated cytotoxicity by human NK cells stimulated with suboptimal doses of IL-12.
Girart MV; Fuertes MB; Domaica CI; Rossi LE; Zwirner NW
J Immunol; 2007 Sep; 179(6):3472-9. PubMed ID: 17804388
[TBL] [Abstract][Full Text] [Related]
20. Interaction of monocytes with NK cells upon Toll-like receptor-induced expression of the NKG2D ligand MICA.
Kloss M; Decker P; Baltz KM; Baessler T; Jung G; Rammensee HG; Steinle A; Krusch M; Salih HR
J Immunol; 2008 Nov; 181(10):6711-9. PubMed ID: 18981088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]